Erectile Dysfunction: Clinical Trials

4 trials for Erectile Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4

Follow Erectile Dysfunction: new trials by email Literature Review of Erectile Dysfunction trials Research Report on Erectile Dysfunction

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care
Stravix lyopreserved placental tissue (LPT), Radical prostatectomy - Prostate Cancer
Phase 2TerminatedJohns Hopkins University32022-04-012026-01-30
Hypoactive Sexual Desire Disorder in Males
Flibanserin, Placebo - Low Libido
Phase 2TerminatedMohit Khera82020-05-082026-01-26
Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction
WC3036-11F/Alprostadil in Vehicle 2.5%, WC3036-12F/Alprostadil in Vehicle 0.5%, WC3036-13P/Vehicle Only 0.5% - Erectile Dysfunction
Phase 2TerminatedWarner Chilcott162013-02-012014-08-12
Phase II Trial of SK3530 in Erectile Dysfunction
SK3530 - Male Erectile Dysfunction
Phase 2TerminatedSK Chemicals Co., Ltd.1202004-09-012006-07-12

Narrower conditions

Prostatic Neoplasms (1)

Broader conditions

Genital Diseases (4)  ·  Genital Diseases, Male (4)  ·  Male Urogenital Diseases (4)  ·  Mental Disorders (4)  ·  Sexual Dysfunction, Physiological (4)  ·  Sexual Dysfunctions, Psychological (4)  ·  Urogenital Diseases (4)  ·  Genital Neoplasms, Male (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Prostatic Diseases (1)  ·  Urogenital Neoplasms (1)

Interventions

2-(5-(4-(2-hydroxyethyl)piperazin-1-ylsulfonyl)-2-n-propoxyphenyl)-5-ethyl-7-n-propyl-3,5-dihydro-4H-pyrrolo(3,2-d)pyrimidin-4-one dihydrochloride (1)  ·  flibanserin (1)

Sponsors

Johns Hopkins University (1)  ·  Mohit Khera (1)  ·  SK Chemicals Co., Ltd. (1)  ·  Warner Chilcott (1)

Countries

United States (3)

Top investigators

Arthur Burnett, MD (1)  ·  Jae-Seung Paick, Doctor (1)  ·  Mohit Khera, MD, MBA, MPH (1)  ·  Vilma Sniukiene, MD (1)